Prognostic relevance of tumour-associated macrophages and von Willebrand factor-positive microvessels in colorectal cancer

被引:72
作者
Lackner, C
Jukic, Z
Tsybrovskyy, O
Jatzko, G
Wette, V
Hoefler, G
Klimpfinger, M
Denk, H
Zatloukal, K
机构
[1] Med Univ Graz, Inst Pathol, A-8036 Graz, Austria
[2] Inst Pathol, A-9020 Klagenfurt, Austria
[3] Barmherzige Bruder Hosp, A-9300 Sankt Veit Glan, Austria
[4] Kaiser Franz Josef Spital Stadt Wien, Pathol Bakteriol Inst, A-1100 Vienna, Austria
关键词
colorectal cancer; microvascular density; macrophages; prognosis;
D O I
10.1007/s00428-004-1051-z
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Tumour-associated macrophages (TAM) are involved in tumour angiogenesis and anti-tumour immune response. In colorectal cancer (CRC), an association of high microvascular density (MVD) and unfavourable prognosis has been reported by some investigators. However, heterogeneous patient groups were studied. We, therefore, analysed the correlation between TAM and MVD and the prognostic relevance of MVD, TAM and T lymphocyte infiltration for long-term survival in a homogeneous group of 70 patients with moderately differentiated cancers of the International Union Against Cancer (UICC) stages II and III, who did not receive chemotherapy. MVD was evaluated using immunohistochemistry with antibodies against CD34 and von Willebrand factor (vWF). TAM and T lymphocytes were visualised with antibodies against CD68 and CD3, respectively. Statistical analysis did not reveal a significant correlation between TAM and T lymphocyte numbers and MVD. Multivariate analysis of immunohistochemical data from all CRC patients and the subgroup of patients with UICC stage-II CRC identified TAM- and vWF-positive microvessel numbers as prognostically relevant markers. Low numbers of TAM- and high numbers of vWF-positive microvessels were associated with an unfavourable prognosis. In conclusion, TAM- and vWF-positive microvessel numbers may serve as independent prognostic markers for patients with UICC stage-II and -III CRC and may help to identify patients with an unfavourable prognosis.
引用
收藏
页码:160 / 167
页数:8
相关论文
共 72 条
  • [1] LYMPHOCYTE INFILTRATES AS A PROGNOSTIC VARIABLE IN FEMALE BREAST-CANCER
    AALTOMAA, S
    LIPPONEN, P
    ESKELINEN, M
    KOSMA, VM
    MARIN, S
    ALHAVA, E
    SYRJANEN, K
    [J]. EUROPEAN JOURNAL OF CANCER, 1992, 28A (4-5) : 859 - 864
  • [2] ABBAS AK, 2000, CELLULAR MOL IMMUNOL, P384
  • [3] Aotake T, 1999, CLIN CANCER RES, V5, P135
  • [4] Banner BF, 1998, AM J CLIN PATHOL, V109, P733
  • [5] CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy
    Bettencourt, MC
    Bauer, JJ
    Sesterhenn, IA
    Connelly, RR
    Moul, JW
    [J]. JOURNAL OF UROLOGY, 1998, 160 (02) : 459 - 465
  • [6] BOSSI P, 1995, CANCER RES, V55, P5049
  • [7] BOUCHER Y, 1992, CANCER RES, V52, P5110
  • [8] The role of vascular endothelial growth factor in blood vessel formation
    Breier, G
    Risau, W
    [J]. TRENDS IN CELL BIOLOGY, 1996, 6 (12) : 454 - 456
  • [9] Should Dukes' B patients receive adjuvant therapy? A statistical perspective
    Buyse, M
    Piedbois, P
    [J]. SEMINARS IN ONCOLOGY, 2001, 28 (01) : 20 - 24
  • [10] Cheng WF, 1999, CANCER, V85, P651, DOI 10.1002/(SICI)1097-0142(19990201)85:3<651::AID-CNCR15>3.0.CO